February 18, 2021 01:57 PM EST

Covid-19 Manufacturing Roundup: Thermo Fisher plant ramps up AstraZeneca vaccine production; Novavax expands Korean manufacturing pact

Conner Mitchell

Shortly after Thermo Fisher’s $878.2 million buyout of Novasep’s viral vector manufacturing business, it took over a plant in Belgium tasked with producing adenovirus …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 Manufacturing Roundup: Thermo Fisher plant ramps up AstraZeneca vaccine production; Novavax expands Korean manufacturing pact

Conner Mitchell

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

CBER's deputy director departs as staff shakeup continues

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

FDA approves first drug to treat ultra-rare lipid storage disease

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

FDA says Ozempic, Wegovy shortage is over

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Covid-19 Man­u­fac­tur­ing Roundup: Ther­mo Fish­er plant ramps up As­traZeneca vac­cine pro­duc­tion; No­vavax ex­pands Ko­re­an man­u­fac­tur­ing pact

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Covid-19 Manufacturing Roundup: Thermo Fisher plant ramps up AstraZeneca vaccine production; Novavax expands Korean manufacturing pact